← Leaderboards
Obi L. Griffith
Washington University
$8,133,812
Attributed
$12,915,856
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,915,856 · 8
By mechanism
U24$7,627,181 · 4
U01$4,076,967 · 2
UE5$696,473 · 1
K22$515,235 · 1
Top collaborators
- Malachi Griffith9 shared
- Ramaswamy Govindan5 shared
- Trudy Gale Oliver5 shared
- Gordana Raca3 shared
- Rohan Dexter Jeremiah1 shared
- Jeffrey T. Leek1 shared
- Alex Handler Wagner1 shared
- Carrie Wright1 shared
Most similar at Washington University
Same institution · by research overlap
- Malachi Griffith$4,536,433
- David J States$3,882,485
- Gordana Raca$290,116
- Leslie M Loew$32,261,482
- Shirley J Dyke$5,819,444
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMutationResourcesGenomicsVariantDatabasesGenesCommunitiesTumorClinically SignificantPrecision OncologyAdoptedWorking GroupDna Sequence AlterationResponseResearch PersonnelClinically RelevantGenomeTargeted TreatmentBaseCrowdsourcingGuidelinesUser-FriendlyClinical Trials
Grant awards (28)
Accelerating the expert-crowdsourcing of cancer variant interpretation in CIViC$809,106
U24 · FY2025 · CA · contact PI
Creation of a knowledgebase of high quality assertions of the clinical actionability of somatic variants in cancer$610,064
U24 · FY2025 · CA
Scalable multi-mode education to increase use of ITCR tools by diverse analysts$696,473
UE5 · FY2024 · CA
Creation of a knowledgebase of high quality assertions of the clinical actionability of somatic variants in cancer$581,256
U24 · FY2024 · CA
Text Mining and Large Language Models for AI-Driven Evidence-Based Functional Annotation of Clinical Variants$300,000
U24 · FY2024 · CA
Genomic Expert Curation Panels for Pediatric Malignancies$268,374
U24 · FY2024 · CA · contact PI
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine$714,234
U24 · FY2023 · CA · contact PI
Creation of a knowledgebase of high quality assertions of the clinical actionability of somatic variants in cancer$642,057
U24 · FY2023 · CA
Genomic Expert Curation Panels for Pediatric Malignancies$283,182
U24 · FY2023 · CA · contact PI
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine$719,412
U24 · FY2022 · CA · contact PI
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer$567,348
U01 · FY2022 · CA
Genomic Expert Curation Panels for Pediatric Malignancies$318,793
U24 · FY2022 · CA · contact PI
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine$733,862
U24 · FY2021 · CA · contact PI
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer$561,139
U01 · FY2021 · CA
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer$778,924
U01 · FY2020 · CA
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine$730,562
U24 · FY2020 · CA · contact PI
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine$157,500
U24 · FY2020 · CA · contact PI
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine$758,779
U24 · FY2019 · CA · contact PI
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer$560,803
U01 · FY2019 · CA
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer$589,596
U01 · FY2018 · CA
DEVELOPMENT OF INFORMATICS RESOURCES FOR INTERPRETATION OF CLINICALLY ACTIONABLE VARIANTS IN CANCER$296,919
U01 · FY2018 · CA · contact PI
DEVELOPMENT OF INFORMATICS RESOURCES FOR INTERPRETATION OF CLINICALLY ACTIONABLE VARIANTS IN CANCER$60,202
U01 · FY2018 · CA · contact PI
DEVELOPMENT OF INFORMATICS RESOURCES FOR INTERPRETATION OF CLINICALLY ACTIONABLE VARIANTS IN CANCER$296,919
U01 · FY2017 · CA · contact PI
Development of a knowledge-driven smMIP assay for ultra-sensitive detection of clinically relevant variants in cancer (1 of 2)$61,948
U01 · FY2017 · CA · contact PI
DEVELOPMENT OF INFORMATICS RESOURCES FOR INTERPRETATION OF CLINICALLY ACTIONABLE VARIANTS IN CANCER$303,169
U01 · FY2016 · CA · contact PI
DEFINING THE REGULATORY, NON-CODING, MUTATIONAL LANDSCAPE OF BREAST CANCER$171,745
K22 · FY2016 · CA · contact PI
DEFINING THE REGULATORY, NON-CODING, MUTATIONAL LANDSCAPE OF BREAST CANCER$171,745
K22 · FY2015 · CA · contact PI
DEFINING THE REGULATORY, NON-CODING, MUTATIONAL LANDSCAPE OF BREAST CANCER$171,745
K22 · FY2014 · CA · contact PI